Figure 1.
Kaplan-Meier analysis of survival in RASB treated and untreated patients. Progression to the primary outcome differed significantly (log-rank, p=0.004). RASB, rennin-angiotensin system blockers
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.